ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $796,000 | +9.0% | 42,209 | -31.9% | 0.00% | 0.0% |
| Q2 2019 | $730,000 | -13.1% | 62,015 | +0.7% | 0.00% | 0.0% |
| Q1 2019 | $840,000 | +37.3% | 61,559 | +3.1% | 0.00% | 0.0% |
| Q4 2018 | $612,000 | -41.0% | 59,717 | -4.2% | 0.00% | 0.0% |
| Q3 2018 | $1,038,000 | +1.4% | 62,339 | -3.8% | 0.00% | 0.0% |
| Q2 2018 | $1,024,000 | +32.1% | 64,815 | +6.2% | 0.00% | 0.0% |
| Q1 2018 | $775,000 | -3.0% | 61,022 | -12.6% | 0.00% | 0.0% |
| Q4 2017 | $799,000 | +90.7% | 69,804 | +104.1% | 0.00% | – |
| Q3 2017 | $419,000 | -18.8% | 34,194 | -24.1% | 0.00% | -100.0% |
| Q2 2017 | $516,000 | +26.5% | 45,060 | +129.5% | 0.00% | 0.0% |
| Q1 2017 | $408,000 | -28.4% | 19,635 | -28.3% | 0.00% | 0.0% |
| Q4 2016 | $570,000 | -73.8% | 27,382 | -58.7% | 0.00% | -66.7% |
| Q3 2016 | $2,175,000 | +29.0% | 66,369 | -1.7% | 0.00% | 0.0% |
| Q2 2016 | $1,686,000 | +68.9% | 67,504 | +65.7% | 0.00% | +50.0% |
| Q1 2016 | $998,000 | +121.3% | 40,737 | +198.1% | 0.00% | +100.0% |
| Q4 2015 | $451,000 | – | 13,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
| Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
| PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
| Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
| PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
| Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
| CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
| Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |